Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2013

01.08.2013 | Original Paper

Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness

verfasst von: Wilhelm Grander, Kathrin Müllauer, Bernhard Koller, Herbert Tilg, Martin Dünser

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A heart rate >90 bpm serves as one of four characteristics defining the systemic inflammatory response syndrome and is used in scoring systems to predict in-hospital mortality of intensive care unit (ICU) patients. Despite its central role in critical illness, specific data regarding the relationship between heart rate and outcome are rare.

Methods

In this post hoc analysis of a prospectively collected database, we analyzed the value of heart rate averaged from four predefined time points during the last 24 h before ICU discharge as a predictor of post-ICU in-hospital and post-hospital mortality in medical ICU patients. Furthermore, the relationship between heart rate and inflammation, as well as the influence of rate control medications on the association between heart rate and outcome were identified.

Results

Among the 702 ICU patients discharged from the ICU, 7.1 % died before hospital discharge. At 4 years of follow-up, post-hospital mortality was 14.4 %. Multivariate Cox proportional hazards models revealed heart rate before ICU discharge (HR 5.95; 95 % CI 1.24–28.63; p = 0.03) as an independent predictor of post-ICU in-hospital mortality. Both heart rate (HR 2.56; 95 % CI, 1.05−6.34; p = 0.04) and the C-reactive protein serum concentration before ICU discharge (HR, 1.26; 95 % CI, 1.09–1.46; p = 0.002) were independently associated with post-hospital mortality. Heart rate control therapy reduced the risk of post-ICU in-hospital (HR 0.38; 95 % CI, 0.18–0.81; p = 0.01) and post-hospital (HR, 0.47; 95 % CI, 0.22–1.00; p = 0.05) mortality.

Conclusion

Heart rate evaluated 24 h before ICU discharge was independently associated with post-ICU in-hospital and post-hospital mortality. Pharmacological interventions to control heart rate may beneficially influence post-ICU mortality.
Literatur
1.
2.
Zurück zum Zitat Hoke RS, Muller-Werdan U, Lautenschlager C et al (2012) Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study. Clin Res Cardiol 101(2):139–147PubMedCrossRef Hoke RS, Muller-Werdan U, Lautenschlager C et al (2012) Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study. Clin Res Cardiol 101(2):139–147PubMedCrossRef
4.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB et al (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28PubMed Bone RC, Balk RA, Cerra FB et al (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28PubMed
5.
Zurück zum Zitat Kannel WB, Kannel C, Paffenbarger RS Jr et al (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113(6):1489–1494PubMedCrossRef Kannel WB, Kannel C, Paffenbarger RS Jr et al (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113(6):1489–1494PubMedCrossRef
6.
Zurück zum Zitat Hansen TW, Thijs L, Boggia J et al (2008) Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 52(2):229–235PubMedCrossRef Hansen TW, Thijs L, Boggia J et al (2008) Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 52(2):229–235PubMedCrossRef
7.
Zurück zum Zitat Kristal-Boneh E, Silber H, Harari G, Froom P (2000) The association of resting heart rate with cardiovascular, cancer and all-cause mortality: eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 21:116–124PubMedCrossRef Kristal-Boneh E, Silber H, Harari G, Froom P (2000) The association of resting heart rate with cardiovascular, cancer and all-cause mortality: eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 21:116–124PubMedCrossRef
8.
Zurück zum Zitat Lechat P, Hulot JS, Escolano S et al (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103(10):1428–1433PubMedCrossRef Lechat P, Hulot JS, Escolano S et al (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103(10):1428–1433PubMedCrossRef
9.
Zurück zum Zitat Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312PubMedCrossRef Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312PubMedCrossRef
10.
Zurück zum Zitat Palatini P, Julius S (2004) Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 26:637–644PubMedCrossRef Palatini P, Julius S (2004) Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 26:637–644PubMedCrossRef
11.
Zurück zum Zitat Swedberg K, Komajda M, Bohm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885PubMedCrossRef Swedberg K, Komajda M, Bohm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885PubMedCrossRef
12.
Zurück zum Zitat Fox K, Ford I, Steg PG et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807–816PubMedCrossRef Fox K, Ford I, Steg PG et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807–816PubMedCrossRef
13.
Zurück zum Zitat Grander W, Dunser M, Stollenwerk B et al (2010) C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 138(4):856–862PubMedCrossRef Grander W, Dunser M, Stollenwerk B et al (2010) C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 138(4):856–862PubMedCrossRef
14.
Zurück zum Zitat Grander W, Luckner G, Orgersen C et al (2011) Peak postoperative C-reactive protein levels and long-term mortality in a mixed surgical ICU population: a retrospective, observational-analytical study. Chirurgia 24(3):125–131 Grander W, Luckner G, Orgersen C et al (2011) Peak postoperative C-reactive protein levels and long-term mortality in a mixed surgical ICU population: a retrospective, observational-analytical study. Chirurgia 24(3):125–131
15.
Zurück zum Zitat Ahmad S, Tejuja A, Newman KD et al (2009) Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 13(6):232PubMedCrossRef Ahmad S, Tejuja A, Newman KD et al (2009) Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 13(6):232PubMedCrossRef
16.
Zurück zum Zitat Kox M, Vrouwenvelder MQ, Pompe JC et al (2011) The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma 29(5):747–755CrossRef Kox M, Vrouwenvelder MQ, Pompe JC et al (2011) The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma 29(5):747–755CrossRef
17.
Zurück zum Zitat Pavlov VA, Tracey KJ (2006) Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 34(Pt 6):1037–1040PubMed Pavlov VA, Tracey KJ (2006) Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 34(Pt 6):1037–1040PubMed
18.
Zurück zum Zitat Gallowitsch-Puerta M, Pavlov VA (2007) Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 80(24–25):2325–2329PubMedCrossRef Gallowitsch-Puerta M, Pavlov VA (2007) Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 80(24–25):2325–2329PubMedCrossRef
19.
Zurück zum Zitat Ferrari R, Censi S, Mastrorilli F, Boraso A (2003) Prognostic effects of heart rate reduction in cardiovascular disease. Eur Heart J Suppl 5(Supplement):G10–G14CrossRef Ferrari R, Censi S, Mastrorilli F, Boraso A (2003) Prognostic effects of heart rate reduction in cardiovascular disease. Eur Heart J Suppl 5(Supplement):G10–G14CrossRef
20.
Zurück zum Zitat Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312PubMedCrossRef Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312PubMedCrossRef
21.
Zurück zum Zitat Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104(13):1477–1482PubMedCrossRef Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104(13):1477–1482PubMedCrossRef
22.
Zurück zum Zitat Ho KM, Lee KY, Dobb GJ et al (2008) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 34(3):481–487PubMedCrossRef Ho KM, Lee KY, Dobb GJ et al (2008) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 34(3):481–487PubMedCrossRef
23.
Zurück zum Zitat Litton E, Ho KM, Chamberlain J et al (2007) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a nested case-control study. Crit Care Resusc 9(1):19–25PubMed Litton E, Ho KM, Chamberlain J et al (2007) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a nested case-control study. Crit Care Resusc 9(1):19–25PubMed
24.
Zurück zum Zitat Al-Subaie N, Reynolds T, Myers A et al (2010) C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 105(3):318–325PubMedCrossRef Al-Subaie N, Reynolds T, Myers A et al (2010) C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 105(3):318–325PubMedCrossRef
25.
Zurück zum Zitat Silvestre J, Coelho L, Povoa P (2010) Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol 10:17PubMedCrossRef Silvestre J, Coelho L, Povoa P (2010) Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol 10:17PubMedCrossRef
26.
Zurück zum Zitat Ranzani OT, Prada LF, Zampieri FG, et al (2012) Failure to reduce C-reactive protein levels more than 25% in the last 24 hours before intensive care unit discharge predicts higher in-hospital mortality: a cohort study. J Crit Care 27(5):525.e9–15 Ranzani OT, Prada LF, Zampieri FG, et al (2012) Failure to reduce C-reactive protein levels more than 25% in the last 24 hours before intensive care unit discharge predicts higher in-hospital mortality: a cohort study. J Crit Care 27(5):525.e9–15
27.
Zurück zum Zitat Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B, INTRINSIC RV Study Investigators (2009) Heart rate predicts outcomes in an implantable. Circulation. 120(21):2040–2045PubMedCrossRef Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B, INTRINSIC RV Study Investigators (2009) Heart rate predicts outcomes in an implantable. Circulation. 120(21):2040–2045PubMedCrossRef
28.
Zurück zum Zitat Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine: MODI (f)Y trial. Clin Res Cardiol 100(10):915–923PubMedCrossRef Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine: MODI (f)Y trial. Clin Res Cardiol 100(10):915–923PubMedCrossRef
29.
Zurück zum Zitat Diaz A, Bourassa MG, Guertin MC et al (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26(10):967–974PubMedCrossRef Diaz A, Bourassa MG, Guertin MC et al (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26(10):967–974PubMedCrossRef
30.
Zurück zum Zitat Fagundes JE, Castro I (2010) Predictive value of resting heart rate for cardiovascular and all-cause mortality. Arq Bras Cardiol 95(6):713–719PubMedCrossRef Fagundes JE, Castro I (2010) Predictive value of resting heart rate for cardiovascular and all-cause mortality. Arq Bras Cardiol 95(6):713–719PubMedCrossRef
31.
Zurück zum Zitat Povoa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28(3):235–243PubMedCrossRef Povoa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28(3):235–243PubMedCrossRef
32.
Zurück zum Zitat Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454PubMedCrossRef Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454PubMedCrossRef
Metadaten
Titel
Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness
verfasst von
Wilhelm Grander
Kathrin Müllauer
Bernhard Koller
Herbert Tilg
Martin Dünser
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2013
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-013-0571-4

Weitere Artikel der Ausgabe 8/2013

Clinical Research in Cardiology 8/2013 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.